Clinical trial Recruiting at 12 sites Observational Ages 40 and up

New classification for sleep apnea based on daytime sleepiness and heart risk

Official title: A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores: A Prospective Observational Cohort Study

Run by Wissenschaftliches Institut Bethanien e.V · NCT06861686 · Data updated 2026-11-12

We will test whether combining daytime sleepiness and cardiovascular risk scores can better predict long-term outcomes for adults newly diagnosed with obstructive sleep apnea.

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment1800 (estimated)
SponsorWissenschaftliches Institut Bethanien e.V
Academic / other
Locations18 sites (Antwerp, Antwerp and 17 other locations)
StatusRecruiting
StartedMarch 24, 2025
Main results expectedMarch 31, 2030
Study endsMarch 31, 2030
Registry record updatedDecember 12, 2025
Trial IDNCT06861686 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40 years or older with newly diagnosed predominantly obstructive sleep apnea (AHI ≥5) who have not received sleep apnea treatment in the past 12 months and have fewer than 30% central events are ideal candidates.

Probably not a fit

Patients with primarily central sleep apnea (>30% central events), those already treated for sleep apnea within the last year, or adults under 40 are unlikely to benefit from this classification.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll adults aged 40 and older with newly diagnosed predominantly obstructive sleep apnea (AHI ≥5) at centers in Belgium and France. Investigators will apply a modified Baveno classification that combines measures of daytime sleepiness and cardiovascular risk, using diagnostic polysomnography or polygraphy per local standards. Participants will be followed over time for objective measures (repeat sleep testing) and subjective outcomes (sleepiness questionnaires and clinical cardiovascular events) without introducing experimental treatments. The aim is to determine whether the new classification correlates with long-term improvement and cardiovascular risk.

Why it matters

Potential benefit: If successful, the classification could help clinicians identify patients at higher cardiovascular risk and tailor monitoring or treatment intensity accordingly.

How similar studies have gone: Similar approaches combining sleepiness and cardiovascular risk have been proposed, but they remain relatively untested in large prospective cohorts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

1. Adult patient ≥40 years at the time of signed informed consent
2. Diagnosis of predominant obstructive sleep apnoea with a total apnoea-hypopnoea index of ≥5 /h based on a diagnostic sleep study (polysomnography or polygraphy, as per local standard). Predominant obstructive sleep apnoea defined as ≥70% of respiratory events classified as obstructive.
3. Signed and dated written informed consent in accordance with ICH-GCP and applicable local regulations

Exclusion criteria

1. \>30% central respiratory events (apnoeas and hypopnoeas) within the diagnostic sleep study
2. Established sleep apnoea treatment within the last 12 months before study inclusion (positive airway pressure, mandibular advancement device, positional therapy)
3. Use, or need for chronic use, of any non-invasive positive pressure ventilation device
4. Participation in an interventional study and/or receiving investigational treatment(s)
5. Significant disease or condition, which, in the opinion of the investigator, may interfere with study procedures or cause concern regarding the patient's ability to participate in the study
6. Patients not expected to comply with the protocol requirements or not expected to complete the trial as scheduled (e.g. chronic alcohol or drug abuse or any other condition that, in the investigator's opinion, makes the patient an unreliable trial participant)

Where it's running

  • UZ Leuven
    Leuven, Vlaams-Brabant, Belgium
    Recruiting
  • Wissenschaftliches Institut Bethanien für Pneumologie e.V.
    Solingen, Germany
    Recruiting
  • Department of Pulmonology, University General Hospital of Alexandroupolis, Medical School, Democritus University of Thrace
    Alexandroupoli, Evros, Greece
    Recruiting
  • University of Crete
    Heraklion, Greece
    Recruiting
  • Istituti Clinici Scientifici Maugeri IRCCS
    Pavia, Italy
    Recruiting
  • Institute of Tuberculosis and Lung Diseases
    Warsaw, Masovian Voivodeship, Poland
    Recruiting
Show 12 more locations
  • Unidade Local de Saúde de Gaia e Espinho ULSGE - Unidade de Patologia do Sons
    Vila Nova de Gaia, Porto District, Portugal
    Recruiting
  • Hospital Beatriz Ângelo, Unidade Local de Saúde Loures-Odivelas
    Loures, Portugal
    Recruiting
  • Clinica Somnolog
    Bucharest, Romania
    Recruiting
  • University of Medicine and Pharmacy Dr. Victor Babes
    Timișoara, Romania
    Recruiting
  • University Clinic of Respiratory and Allergic Diseases Golnik
    Golnik, Slovenia
    Recruiting
  • Ege University, Faculty of Medicine, Department of Respiratory Medicine
    Izmir, Turkey (Türkiye)
    Recruiting
  • Antwerp University Hospital
    Antwerp, Antwerp, Belgium
    Not yet recruiting
  • Centre Hospitalier Universitaire Grenoble Alpes
    Grenoble, Isère, France
    Not yet recruiting
  • Division of Pulmonology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Medical School
    Athens, Greece
    Not yet recruiting
  • Respiratory Failure Unit, G. Papanikolaou Hospital
    Thessaloniki, Greece
    Not yet recruiting
  • Istituto Auxologico Italiano
    Milan, Italy
    Not yet recruiting
  • Klinik für Pneumologie Universitätsspital Zürich
    Zurich, Switzerland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.